arrow
M

Maud Ngo-Camus

unicancer
H指数:22
被引数:2,553

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development

破译癌症的耐药机制: MATCH-R研究的最终报告,重点是分子驱动和PDX的发展

2024-10-040
OAAI
Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer

用于晚期胰腺癌功能精准医学的类器官

2024-10-012
OA
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer

去势抵抗性前列腺癌侵袭性变异体新模型的建立

2024-06-011
PRE
Codon-specific KRAS mutations predict survival in advanced pancreatic cancer
2024-01-160
PRE
Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA

胆道癌的分子谱分析揭示了循环和组织肿瘤DNA之间不同的基因组景观

2024-01-084
OA
Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study
2023-11-044
OAAI
MatchR a preclinical platform of models resistant to innovative therapies

MatchR是对创新疗法有抵抗力的模型的临床前平台

2023-04-040
PRE
Molecular landscape of clonal hematopoiesis in patients with lung cancer: First results of the CHIC study
2023-04-040
PRE
Epigenetic gene alterations in metastatic solid tumours: results from the prospective precision medicine MOSCATO and MATCH-R trials
2022-09-011
PRE
Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer
2022-09-010
OAAI
Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test
CELLS
IF5.2
2022-06-1112
OAAI
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy

在Gustave Roussy进行的MATCH-R重复活检试验的可行性和首次报告

2020-09-0821
OAAI
Novel preclinical models of aggressive variants of castration-resistant prostate cancer
2020-08-150
PRE
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer

通过转移性前列腺癌中循环肿瘤细胞的全外显子组测序对转移突变内容的可访问和独特见解

2020-08-0124
OAAI
Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report

非小细胞肺癌患者EGFR酪氨酸激酶抑制剂耐药时可能经常出现致癌融合: 一份简要报告

2020-06-0117
OA